Claiborne Cary J
SEC insider (Form 3/4/5 filer). CIK 0001370930. Chief Executive Officer at ADIAL PHARMACEUTICALS, INC. (ADIL) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in GLEN ALLEN, VA.
Companies Claiborne Cary J has filed insider reports for
- ADIAL PHARMACEUTICALS, INC. (ADIL): Director, Officer, Chief Executive Officer
- NeuroSense Therapeutics Ltd. (NRSN): Director
Claiborne Cary J
CIK: 0001370930
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
